Challenge

"New Science," like personalized cell and gene therapies, is bringing together the best in science and health technology to raise the standard of care. However, many companies struggle with taking personalized medicine to market effectively. Delivering these therapies often involves a series of time-critical steps involving a complex chain of participants. Along the way, siloed solutions make it challenging to manage the effectiveness of a therapy’s delivery and a patient’s experience.

How can personalized medicine providers manage therapy delivery so patients can more effectively and quickly realize the benefits of these ground-breaking treatments?

Delivering patient-specific medicines against a time clock

A clinical-stage company developing cell and gene therapies has produced a treatment for a severe genetic disease. With the new therapy, most patients can now forgo a lifetime of monthly treatments for a single gene therapy treatment.

Gene therapy involves extracting and modifying a patient’s own stem cells using a viral vector, then reintroducing the modified cells into the patient. In order to provide personalized treatment to these patients from enrollment to infusion, each patient’s medical information, along with supply chain and manufacturing processes, must be tightly coordinated to adhere to high-quality standards and critical timelines. Our biopharma client needed to develop highly streamlined and coordinated capabilities that provide a "white-glove" experience for healthcare organizations while delivering each patient’s specific therapy to them at the right place and time. The Accenture INTIENT platform is helping our client provide personalized treatments for patients every step of the way.

What Accenture did

We helped our biopharma client implement a comprehensive, patient-centered platform in only four months—in time for the therapy’s launch. Using the Precision Medicine Delivery components of the INTIENT Patient platform, Accenture is helping to manage the treatment’s complex processes, including:

  • Ordering the therapy.
  • Tracking the manufacture of the personalized gene therapy.
  • Collecting and delivering the product in a 24- to 48-hour timeframe.
  • Coordinating treatment and follow-up.
  • Managing payment data collection.

The solution provides a central platform from which the company and partners (such as healthcare professionals, hospitals and logistics coordinators) can gain insight into the patient’s care and coordinate treatment. The platform will also enable additional therapies, centers and users to be onboarded across countries as they are approved.

INTIENT Patient is fully integrated with the company’s systems, including logistics, CRM, identity management and patient master data management. The platform meets data privacy regulations and encrypts patient data.

INTIENT Patient enables all partners to support the patient through a complex treatment and recovery process with:

Patient case management framework

The patient case management framework provides a real-time view into the patient’s therapy journey and manages required patient touchpoints.

Healthcare professional portal

The multi-lingual portal allows HCPs to onboard patients and align on treatment from initiation through therapy and post-treatment support.

View All

People and culture

The open nature of the platform means that our client can easily integrate new partners and add patient services as needed to support a broader patient population—and to give treatment access to as many patients as possible. In the future, the company will be able to implement additional INTIENT Patient capabilities, including artificial intelligence, smart automation, machine learning and advanced analytics, positioning it to deliver cell and gene therapy treatments more effectively and quickly. Accenture is helping the company grow its core capabilities so it can focus on creating new, personalized therapies to help patients in need.

The Accenture INTIENT platform delivers outcome-based services that support patients from pre-diagnosis through ongoing treatment. It features the end-to-end capabilities needed to deliver a better, more coordinated patient experience. INTIENT Patient is preconfigured to handle a broad range of capabilities, such as patient onboarding and identification. These capabilities can be easily customized for each company or region, decreasing the time involved to get the platform up and running—and serving patients.

Value delivered

With support from INTIENT Patient, our client can seamlessly manage the patient journey from enrollment through infusion in coordination with multiple partners.

The open nature of the platform means that our client can easily integrate new partners and add patient services as needed to support a broader patient population—and to give treatment access to as many patients as possible. In the future, the company will be able to implement additional INTIENT Patient capabilities, including artificial intelligence, smart automation, machine learning and advanced analytics, positioning it to deliver cell and gene therapy treatments more effectively and quickly. Accenture is helping the company grow its core capabilities so it can focus on creating new, personalized therapies to help patients in need.

The smooth processes help patients get the high-quality care they need, when and where they need it:

Revolutionary treatment is helping patients improve their quality of life without monthly therapies.

Patients have peace of mind thanks to consistent support from their case managers, who guide them throughout the treatment process.

HCPs have one place to check the status of a patient to support consistent quality of care.

Case managers receive reminders and guided tasks to ensure a complete and timely treatment process.

View All
Subscription Center
Stay in the Know with Our Newsletter Stay in the Know with Our Newsletter